Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Manifestation and treatment in a cleidocranial dysplasia patient with a RUNX2 (T420I) mutation.

Lee C, Jung HS, Baek JA, Leem DH, Ko SO.

Maxillofac Plast Reconstr Surg. 2015 Nov 12;37(1):41. eCollection 2015 Dec.

2.

Generation of cleidocranial dysplasia-specific human induced pluripotent stem cells in completely serum-, feeder-, and integration-free culture.

Yamasaki S, Hamada A, Akagi E, Nakatao H, Ohtaka M, Nishimura K, Nakanishi M, Toratani S, Okamoto T.

In Vitro Cell Dev Biol Anim. 2016 Feb;52(2):252-64. doi: 10.1007/s11626-015-9968-x. Epub 2015 Nov 11.

3.

Odontomas and supernumerary teeth: is there a common origin?

Pippi R.

Int J Med Sci. 2014 Nov 12;11(12):1282-97. doi: 10.7150/ijms.10501. eCollection 2014. Review.

4.

A new phenotypic variant in cleidocranial dysplasia (CCD) associated with mutation c.391C>T of the RUNX2 gene.

Callea M, Fattori F, Yavuz I, Bertini E.

BMJ Case Rep. 2012 Dec 5;2012. pii: bcr1220115422. doi: 10.1136/bcr-12-2011-5422.

5.

In vitro differentiation and mineralization of dental pulp stem cells on enamel-like fluorapatite surfaces.

Wang X, Jin T, Chang S, Zhang Z, Czajka-Jakubowska A, Nör JE, Clarkson BH, Ni L, Liu J.

Tissue Eng Part C Methods. 2012 Nov;18(11):821-30. doi: 10.1089/ten.TEC.2011.0624. Epub 2012 Jun 25.

6.

RUNX2 mutations in Taiwanese patients with cleidocranial dysplasia.

Lin WD, Lin SP, Wang CH, Tsai Y, Chen CP, Tsai FJ.

Genet Mol Biol. 2011 Apr;34(2):201-4. Epub 2011 Apr 1.

7.

Molecular genetics of supernumerary tooth formation.

Wang XP, Fan J.

Genesis. 2011 Apr;49(4):261-77. doi: 10.1002/dvg.20715. Epub 2011 Apr 1. Review.

8.

Development and characterization of a mouse floxed Bmp2 osteoblast cell line that retains osteoblast genotype and phenotype.

Wu LA, Feng J, Wang L, Mu YD, Baker A, Donly KJ, Harris SE, MacDougall M, Chen S.

Cell Tissue Res. 2011 Mar;343(3):545-58. doi: 10.1007/s00441-010-1120-3. Epub 2011 Jan 27.

9.

The Role of RUNX2 in Osteosarcoma Oncogenesis.

Martin JW, Zielenska M, Stein GS, van Wijnen AJ, Squire JA.

Sarcoma. 2011;2011:282745. doi: 10.1155/2011/282745. Epub 2010 Dec 9.

10.

Immortalized mouse floxed Bmp2 dental papilla mesenchymal cell lines preserve odontoblastic phenotype and respond to BMP2.

Wu LA, Feng J, Wang L, Mu YD, Baker A, Donly KJ, Gluhak-Heinrich J, Harris SE, MacDougall M, Chen S.

J Cell Physiol. 2010 Oct;225(1):132-9. doi: 10.1002/jcp.22204.

11.

The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-beta.

Han MS, Kim HJ, Wee HJ, Lim KE, Park NR, Bae SC, van Wijnen AJ, Stein JL, Lian JB, Stein GS, Choi JY.

J Cell Biochem. 2010 May;110(1):97-103. doi: 10.1002/jcb.22516.

12.

Severe cleidocranial dysplasia and hypophosphatasia in a child with microdeletion of the C-terminal region of RUNX2.

El-Gharbawy AH, Peeden JN Jr, Lachman RS, Graham JM Jr, Moore SR, Rimoin DL.

Am J Med Genet A. 2010 Jan;152A(1):169-74. doi: 10.1002/ajmg.a.33146.

13.

RUNX2 mutations in Chinese patients with cleidocranial dysplasia.

Li Y, Pan W, Xu W, He N, Chen X, Liu H, Darryl Quarles L, Zhou H, Xiao Z.

Mutagenesis. 2009 Sep;24(5):425-31. doi: 10.1093/mutage/gep025. Epub 2009 Jun 10.

14.

Genetic analysis of familial non-syndromic primary failure of eruption.

Frazier-Bowers SA, Simmons D, Koehler K, Zhou J.

Orthod Craniofac Res. 2009 May;12(2):74-81. doi: 10.1111/j.1601-6343.2009.01440.x.

15.

A Runx2 threshold for the cleidocranial dysplasia phenotype.

Lou Y, Javed A, Hussain S, Colby J, Frederick D, Pratap J, Xie R, Gaur T, van Wijnen AJ, Jones SN, Stein GS, Lian JB, Stein JL.

Hum Mol Genet. 2009 Feb 1;18(3):556-68. doi: 10.1093/hmg/ddn383. Epub 2008 Nov 20.

16.

p204, a p200 family protein, as a multifunctional regulator of cell proliferation and differentiation.

Luan Y, Lengyel P, Liu CJ.

Cytokine Growth Factor Rev. 2008 Oct-Dec;19(5-6):357-69. doi: 10.1016/j.cytogfr.2008.11.002. Epub 2008 Nov 21. Review.

17.

Intragenic microdeletion of RUNX2 is a novel mechanism for cleidocranial dysplasia.

Lee MT, Tsai AC, Chou CH, Sun FM, Huang LC, Yen P, Lin CC, Liu CY, Wu JY, Chen YT, Tsai FJ.

Genomic Med. 2008 Jan;2(1-2):45-9. doi: 10.1007/s11568-008-9024-y. Epub 2008 Aug 12.

18.

A novel RUNX2 missense mutation predicted to disrupt DNA binding causes cleidocranial dysplasia in a large Chinese family with hyperplastic nails.

Tang S, Xu Q, Xu X, Du J, Yang X, Jiang Y, Wang X, Speck N, Huang T.

BMC Med Genet. 2007 Dec 31;8:82. doi: 10.1186/1471-2350-8-82.

19.

Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles.

Matheny CJ, Speck ME, Cushing PR, Zhou Y, Corpora T, Regan M, Newman M, Roudaia L, Speck CL, Gu TL, Griffey SM, Bushweller JH, Speck NA.

EMBO J. 2007 Feb 21;26(4):1163-75. Epub 2007 Feb 8.

20.

Dysregulation of chondrogenesis in human cleidocranial dysplasia.

Zheng Q, Sebald E, Zhou G, Chen Y, Wilcox W, Lee B, Krakow D.

Am J Hum Genet. 2005 Aug;77(2):305-12. Epub 2005 Jun 10.

Items per page

Supplemental Content

Write to the Help Desk